Vanguard Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.09M | Buy |
|
|||||
|
2025
Q2 | $4.32M | Sell |
|
|||||
|
2025
Q1 | $5.39M | Buy |
|
|||||
|
2024
Q4 | $12M | Sell |
|
|||||
|
2024
Q3 | $19.2M | Sell |
|
|||||
|
2024
Q2 | $16.4M | Buy |
|
|||||
|
2024
Q1 | $23.9M | Buy |
|
|||||
|
2023
Q4 | $11.3M | Buy |
|
|||||
|
2023
Q3 | $3.58M | Buy |
|
|||||
|
2023
Q2 | $5.23M | Sell |
|
|||||
|
2023
Q1 | $6.63M | Buy |
|
|||||
|
2022
Q4 | $12.2M | Buy |
|
|||||
|
2022
Q3 | $17.7M | Buy |
|
|||||
|
2022
Q2 | $14.8M | Sell |
|
|||||
|
2022
Q1 | $49.1M | Buy |
|
|||||
|
2021
Q4 | $64.9M | Buy |
|
|||||
|
2021
Q3 | $86.6M | Buy |
|
|||||
|
2021
Q2 | $53.2M | Buy |
|
|||||
|
2021
Q1 | $14.4M | Sell |
|
|||||
|
2020
Q4 | $15M | Buy |
|